文献速递瓣膜外科

继发性二尖瓣反流:修复与置换的波兰国家注册研究

Repair or Replacement for Secondary Mitral Regurgitation: Results From Polish National Registry.
PubMed 文献 · Ann Thorac Surg · 2021-02-03

该研究基于波兰国家心脏手术注册数据库,纳入2006至2017年间因功能性或缺血性二尖瓣反流行二尖瓣修复或置换的患者,排除合并其他手术及再次或急诊病例。共7633例患者中,5840例(77%)行修复,1793例(23%)行置换。

要点

  • 继发性二尖瓣反流行修复术较置换术与更好的长期生存相关。
  • 置换是死亡的独立预测因素(HR 1.32,95%CI 1.17-1.49)。
  • 倾向性匹配后置换组长期死亡率仍显著更高(HR 1.24)。

核心结论

  • 继发性二尖瓣反流行二尖瓣修复较置换与生存获益相关。

研究设计与样本

  • 基于波兰国家心脏手术注册数据库的回顾性队列研究,纳入2006至2017年间因功能性或缺血性二尖瓣反流行修复或置换的患者,排除合并冠状动脉旁路移植或三尖瓣手术以外其他手术以及再次或急诊病例,共7633例。

主要发现

  • 全队列中5840例(77%)行修复,1793例(23%)行置换。

临床怎么用

  • 在继发性二尖瓣反流的外科决策中,应优先考虑二尖瓣修复以改善长期生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal surgical strategy (repair vs replacement) for patients with secondary mitral (MV) regurgitation is questionable. METHODS: Patients who underwent MV repair or replacement for functional or ischemic mitral regurgitation between 2006 and 2017 were identified in Polish National Registry of Cardiac Surgery Procedures. Patients, who underwent additional procedures other than coronary artery bypass grafting or tricuspid valve surgery, as well as redo or emergency cases, were excluded. The long-term survival was verified based on National Health Fund registry. The survival was compared between MV repair and replacement both in the whole cohort and after propensity score matching. The Cox regression was used to seek for independent predictors of survival. RESULTS: Of 7633 identified patients, 1793 (23%) underwent MV replacement and 5840 (77%) underwent MV repair. Coronary artery bypass surgery was performed together with MV repair in 3992 (69%) patients and together with MV replacement in 915 (52%) patients (P < .001). Tricuspid valve surgery was added to 1393 (24%) MV repairs and to 561 (32%) MV replacements (P < .001). The crude actuarial 5-year survival was 71% (95% confidence interval [CI], 70%-72%) in the repair group and 66% (95% CI, 63%-68%) in the replacement group (P < .001). MV replacement was an independent predictor of mortality (hazard ratio, 1.32; 95% CI, 1.17-1.49) (P < .001) in Cox regression modeling. In the propensity-matched cohort (1105 pairs), the long-term mortality was also significantly higher in the replacement group (hazard ratio, 1.24; 95% CI, 1.06-1.45; P = .008). CONCLUSIONS: Repair of secondary mitral regurgitation has an associated survival benefit compared with MV replacement.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Deja MA, Malinowski M, Widenka K, et al. Repair or Replacement for Secondary Mitral Regurgitation: Results From Polish National Registry. Ann Thorac Surg. 2021. PMID: 33545151. doi:10.1016/j.athoracsur.2020.12.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。